Trial Profile
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Chronic limb-threatening ischemia; Peripheral artery restenosis
- Focus Therapeutic Use
- Acronyms K-ELUVIA
- 26 Apr 2018 New trial record